Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study
Introduction Several surveys report that post-COVID-19 patients (pts) could be at risk of persistent emotional distress, fatigue and impaired neurocognitive function (NCF). Objectives The aim was to assess emotional distress, fatigue and NCF in order to provide adequate care. Methods Patients wit...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822012615/type/journal_article |
_version_ | 1797616361193603072 |
---|---|
author | A. Rogiers S. Launay G. Duque E. Soukias S. Van Eycken T. Besse-Hammer D. Sanchez-Rodriguez M. Chalon M.-D. Gazagne E. Maillart F. Benoit M. Surquin F. Corrazza O. Michel C. Kornreich |
author_facet | A. Rogiers S. Launay G. Duque E. Soukias S. Van Eycken T. Besse-Hammer D. Sanchez-Rodriguez M. Chalon M.-D. Gazagne E. Maillart F. Benoit M. Surquin F. Corrazza O. Michel C. Kornreich |
author_sort | A. Rogiers |
collection | DOAJ |
description |
Introduction
Several surveys report that post-COVID-19 patients (pts) could be at risk of persistent emotional distress, fatigue and impaired neurocognitive function (NCF).
Objectives
The aim was to assess emotional distress, fatigue and NCF in order to provide adequate care.
Methods
Patients with persistent physical or mental symptoms, at least 8 weeks post-COVID-19, were eligible for this ongoing prospective longitudinal single center trial. Data on depression, anxiety, cognition, post-traumatic stress symptoms (PTSS) and fatigue were collected using 4 validated questionnaires at study entry (T0) and at 6 months (T1).
Results
Ninety-three pts were recruited between November 2020-March 2021. Test results from 64 eligible pts (15 male pts) were analyzed at T0; 63 pts (98%) were treated in outpatient settings. Median age was 47 years [range 27-75]). Median time since COVID-19 was 29 weeks [range 8-53]. Twenty-two pts (34%) had a history of psychiatric disorders. According to the Hospital Anxiety Depression Scale (HADS), 44 pts (73%) reported anxiety symptoms and 26 pts (41%) reported depressive symptoms; 48 pts (69%) reported cognitive complaints according to the Cognitive Failure Questionnaire and 29 pts (45%) suffered from PTSS, according to the Post-Traumatic Stress Disorder Checklist-Civilian Version (PCL-C). Fifty-five pts (86%) had an elevated score on the Fatigue Severity Scale, indicating severe fatigue. Twenty-seven pts (42%) were still on sick leaf. Diminished social support and psychiatric history were predictive factors for neurocognitive dysfunction and PTSS.
Conclusions
A majority of patients who recovered physically from COVID-19, are at risk for suffering from persistent anxiety, PTSS and neurocognitive dysfunction.
Disclosure
No significant relationships.
|
first_indexed | 2024-03-11T07:39:53Z |
format | Article |
id | doaj.art-35ebbc55212844a59128276c35cdfaf9 |
institution | Directory Open Access Journal |
issn | 0924-9338 1778-3585 |
language | English |
last_indexed | 2024-03-11T07:39:53Z |
publishDate | 2022-06-01 |
publisher | Cambridge University Press |
record_format | Article |
series | European Psychiatry |
spelling | doaj.art-35ebbc55212844a59128276c35cdfaf92023-11-17T05:08:39ZengCambridge University PressEuropean Psychiatry0924-93381778-35852022-06-0165S496S49610.1192/j.eurpsy.2022.1261Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective studyA. Rogiers0S. Launay1G. Duque2E. Soukias3S. Van Eycken4T. Besse-Hammer5D. Sanchez-Rodriguez6M. Chalon7M.-D. Gazagne8E. Maillart9F. Benoit10M. Surquin11F. Corrazza12O. Michel13C. Kornreich14CHU Brugmann, Department Of Psychiatry, Brussels, Belgium Vrije Universiteit Brussel, Faculty Of Medicine, Brussels, BelgiumCHU Brugmann, Department Of Psychiatry, Brussels, BelgiumCHU Brugmann, Department Of Psychiatry, Brussels, BelgiumCHU Brugmann, Department Of Psychiatry, Brussels, BelgiumCHU Brugmann, Department Of Psychiatry, Brussels, BelgiumCHU Brugmann, Clinical Trial Department, Brussels, BelgiumCHU Brugmann, Geriatry, Brussels, BelgiumCHU Brugmann, Physical Medicine And Rehabilitation, Brussels, BelgiumCHU Brugmann, Neurology, Brussels, BelgiumCHU Brugmann, Department Of Infectious Diseases, Brussels, BelgiumCHU Brugmann, Geriatry, Brussels, BelgiumCHU Brugmann, Geriatry, Brussels, BelgiumCHU Brugmann, Immunology, Brussels, Belgium Université Libre de Bruxelles, Faculty Of Medicine, Brussels, BelgiumCHU Brugmann, Immunology, Brussels, Belgium Université Libre de Bruxelles, Faculty Of Medicine, Brussels, BelgiumCHU Brugmann, Department Of Psychiatry, Brussels, Belgium Université Libre de Bruxelles, Faculty Of Medicine, Brussels, Belgium Introduction Several surveys report that post-COVID-19 patients (pts) could be at risk of persistent emotional distress, fatigue and impaired neurocognitive function (NCF). Objectives The aim was to assess emotional distress, fatigue and NCF in order to provide adequate care. Methods Patients with persistent physical or mental symptoms, at least 8 weeks post-COVID-19, were eligible for this ongoing prospective longitudinal single center trial. Data on depression, anxiety, cognition, post-traumatic stress symptoms (PTSS) and fatigue were collected using 4 validated questionnaires at study entry (T0) and at 6 months (T1). Results Ninety-three pts were recruited between November 2020-March 2021. Test results from 64 eligible pts (15 male pts) were analyzed at T0; 63 pts (98%) were treated in outpatient settings. Median age was 47 years [range 27-75]). Median time since COVID-19 was 29 weeks [range 8-53]. Twenty-two pts (34%) had a history of psychiatric disorders. According to the Hospital Anxiety Depression Scale (HADS), 44 pts (73%) reported anxiety symptoms and 26 pts (41%) reported depressive symptoms; 48 pts (69%) reported cognitive complaints according to the Cognitive Failure Questionnaire and 29 pts (45%) suffered from PTSS, according to the Post-Traumatic Stress Disorder Checklist-Civilian Version (PCL-C). Fifty-five pts (86%) had an elevated score on the Fatigue Severity Scale, indicating severe fatigue. Twenty-seven pts (42%) were still on sick leaf. Diminished social support and psychiatric history were predictive factors for neurocognitive dysfunction and PTSS. Conclusions A majority of patients who recovered physically from COVID-19, are at risk for suffering from persistent anxiety, PTSS and neurocognitive dysfunction. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S0924933822012615/type/journal_articleCovid-19cognitive functionpost-traumatic stress symptomsAnxiety |
spellingShingle | A. Rogiers S. Launay G. Duque E. Soukias S. Van Eycken T. Besse-Hammer D. Sanchez-Rodriguez M. Chalon M.-D. Gazagne E. Maillart F. Benoit M. Surquin F. Corrazza O. Michel C. Kornreich Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study European Psychiatry Covid-19 cognitive function post-traumatic stress symptoms Anxiety |
title | Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study |
title_full | Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study |
title_fullStr | Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study |
title_full_unstemmed | Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study |
title_short | Persistent emotional stress, fatigue and impaired neurocognitive function in recovered COVID-19 patients: a longitudinal prospective study |
title_sort | persistent emotional stress fatigue and impaired neurocognitive function in recovered covid 19 patients a longitudinal prospective study |
topic | Covid-19 cognitive function post-traumatic stress symptoms Anxiety |
url | https://www.cambridge.org/core/product/identifier/S0924933822012615/type/journal_article |
work_keys_str_mv | AT arogiers persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT slaunay persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT gduque persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT esoukias persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT svaneycken persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT tbessehammer persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT dsanchezrodriguez persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT mchalon persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT mdgazagne persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT emaillart persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT fbenoit persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT msurquin persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT fcorrazza persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT omichel persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy AT ckornreich persistentemotionalstressfatigueandimpairedneurocognitivefunctioninrecoveredcovid19patientsalongitudinalprospectivestudy |